Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB
Research shows that approximately 15-20% of GLP-1 users may gain weight or fail to lose weight, often due to factors unrelated to medication failure
Phylander Pannell, 49, of Largo, Maryland, joined a patient study after cycles of losing and then regaining weight
With these data, it is apparent the role GLP-1 and GLP-1/GIP medications will play in the future, necessitating a proper understanding of their side effect profile and complications that may arise
There are also other conditions that can be treated with UAE: Adenomyosis: This is a condition where the inner lining of the uterus breaks through the muscle wall